SOL Group completed the acquisition of an 80% stake in Aenduo.

SOL Group, an Italian multinational corporation specializing in technical and medical gases and home-healthcare services, completed the acquisition of an 80% stake in Aenduo, an Italian telemedicine software start-up specialising in remote patient monitoring of respiratory patients. Financial terms were not disclosed. “We are very happy to join the great SOL family. Thanks to the support and skills of the Group, we will be able to further strengthen our mission, offering our clients and the market increasingly advanced technological solutions based also on artificial intelligence,” Marcello Pediconi, Aenduo Founder and CEO.